The efficacy and safety of FOLFOXIRI for unresectable advanced rectal cancer : a prospective observational study
Not Applicable
- Conditions
- Rectal Cancer
- Registration Number
- JPRN-UMIN000040275
- Lead Sponsor
- Kanagawa Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Synchronous multiple malignancy or metachronous multiple malignancy within 5 years disease free interval. 2.Active infections, including HBs antigen positive 3.Body temperature >= 38 degrees Celsius 4.Serious complications 5.Currently treated with systemic steroids or immunosuppressive agents 6.Not appropriate for the trial by other reasons
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method